POST Online Media Lite Edition


ZIVO Bioscience appoints two vice presidents

Christian Fernsby |
Keego Harbor, Mi., USA - ZIVO Bioscience, a biotech/agtech company, announced the addition of Christine O'Neil and David Lafond to its leadership team.

Article continues below

Christine O'Neil joins the team as Vice President, Corporate Development and has taken on the responsibility of building the health and wellness business for ZIVO.

Ms. O'Neil has held significant business development and senior executive positions over the past 30 years with firms such as Johnson and Johnson, BASF/Cognis, Hoechst/Nutrinova, DSM/Tosoh, Chromocell Corporation, Ajinomoto and Dow Chemical.

In these roles, Ms. O'Neil had responsibility for managing organizations focused on developing and launching new business platforms in the health & nutrition, biotechnology and specialty ingredient markets for leading firms such as: The Coca-Cola Company, Nestle, Kellogg's, PepsiCo., Wrigley/MARS, Danone, General Mills and many others.

David Lafond joins the Company as Vice President, Innovation ab Technology, with over 40 years of experience in food research and product development, and together with Christine has been assigned the role of developing the new business and product innovation pipeline.

Over his career, Dr. LaFond held product development and executive management positions for companies such as: Kraft, Quaker Oats, Keebler, and the Kellogg Company.

In these roles, he had the responsibility of launching new food product innovations and developing new opportunities by finding and incorporating external technologies into the innovation pipeline.

Mr. Lafond holds a Ph.D. in Food Science from Michigan State University, where he studied physical properties of fiber and related them in clinical work to hormonal signaling for appetite control.